8-K
Current Report
Damora Therapeutics, Inc. Filed Acc 0001564590-21-000619
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading glto-8k_20210108.htm…